Neurocrine Biosciences' (NASDAQ:NBIX) underlying earnings growth outpaced the notable return generated for shareholders over the past three years
It's been a soft week for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares, which are down 19%. But we wouldn't complain about the gain over the last three years. In that time the stock gained 43%, ...
Institutional investors own a significant stake of 40% in Deterra Royalties Limited (ASX:DRR)
Key Insights Given the large stake in the stock by institutions, Deterra Royalties' stock price might be vulnerable ...